Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | University of Leicester |
| Country | United Kingdom |
| Start Date | Sep 30, 2024 |
| End Date | Sep 29, 2028 |
| Duration | 1,460 days |
| Number of Grantees | 2 |
| Roles | Student; Supervisor |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2925149 |
In this exciting joint PhD project between the University of Leicester (UoL) and the University of Birmingham (UoB), the student will join a collegiate international consortium investigating lung immunity to tuberculosis (TB) and driving innovation in the TB vaccine pipeline. Development of an effective vaccine is the single most effective tool to reduce the worldwide TB.
The multi-million Euro consortium brings together fundamental immunologists, clinical specialists, experts in non-human primate models and vaccine developers and manufacturers.
The student will investigate the fundamental aspects of immune protection using immunology, immunohistology, flow cytometry, bioinformatics analysis and will learn in vivo imaging and spatial transcriptomics.
The project will focus on the the ability of T cells to undertake adhesion and migration into the lung of TB-infected mice (UoL).
At UoB, multi-cellular in vitro models of leucocyte adhesion and migration will used to dissect the role of specific molecules in T cell migration.
A unique aspect of this studentship is the ability to undertake in vitro and in vivo models in the context of complementary human and non-human primate data.
This is a super opportunity because of the range of techniques and approaches, the networking and the potential for internationalization of the student's experience.
University of Leicester
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant